✦ LIBER ✦

396: Everolimus in de novo heart transplant recipients: Six month data on cyclosporine reduction and impact on renal function

✍ Scribed by A. Keogh; S.S. Wang; A. Zuckermann; H. Ross; M. Frigerio; H. Eisen; C. Bara; G. Laufer; M. Cotrufo; S. Lena; C. Sips

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

12-month safety and efficacy of everolim

✍ Helio Tedesco-Silva Jr; Stefan Vitko; Julio Pascual; Josette Eris; John C. Magee 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 504 KB

267: Impact of cyclosporine C2 monitorin

✍ M. Cantarovich; N. Giannetti; M. deB. Edwardes; G. Fontaine; R. Chartier; E. Cyr 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Longitudinal assessment of everolimus in

✍ Kovarik, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

467: The Impact on Renal Function of an

✍ P. Boissonnat; F. Noel-Baron; S. Gaillard; C. Mercier; A. Roussoulieres; L. Sebb 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Efficacy and safety of de novo or early

✍ Jacques Dantal; François Berthoux; Marie-Christine Moal; Lionel Rostaing; Christ 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB

400: A French multicenter prospective ra

✍ P. Boissonnat; S. Gaillard; F. Noel-Baron; C. Mercier; A. Roussoulieres; O. Bast 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 165 KB